{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Foncologypodcast.simplecast.com%2Fepisodes%2Ffaq-improving-cml-therapy-rVIkLdCd","width":444,"version":"1.0","type":"rich","title":"Improving Outcomes for Patients With CML With TKIs: FAQ Podcast","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/86952976-b928-4317-884c-2c7ba3b2ae4d/488f3e5a-6a66-4916-8f0f-26534084e3b0/cliniciansxchange-podcast-cml.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/1a31eaf8-eb08-48e8-8db1-d5c7d9c061b7\" height=\"200\" width=\"100%\" title=\"Improving Outcomes for Patients With CML With TKIs: FAQ Podcast\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Listen to leukemia experts Prof. Dr. med Tim Henrik Brümmendorf; Jorge Cortes, MD; and Carlo Gambacorti-Passerini, MD, answer audience questions from live CCO Webinars on optimizing TKI treatments for patients with chronic-phase chronic myeloid leukemia (CML)."}